Earlier today Nuvo announced today that for the first time, expectant mothers in the U.S. will have access to INVU, a remote monitoring platform that enables virtual fetal wellness check-ins with their doctors from any location. INVU, an FDA-cleared, prescription-initiated device will be accessible through a commercialization agreement between Nuvo and Axia Women’s Health, a women’s health network of more than 400 providers and 150 women’s health centers across Pennsylvania, New Jersey, Indiana, Ohio and Kentucky.
Under the agreement, Axia Women’s Health providers will be able to prescribe INVU to expectant mothers, who will wear the INVU sensor band during virtual visits with their physicians. During these visits, a live reading allows the mother to access simplified data and insights via the paired INVU app, while the provider receives fetal and maternal heart rate tracings comparable to the fetal viability checks that normally occur in prenatal visits.
As the U.S. continues to struggle with the COVID-19 pandemic, Axia’s pregnancy care providers will be able to perform remote fetal wellness checks outside of a clinical setting. This is imperative since, as reported by the CDC in early November, pregnant women are at an increased risk of developing severe cases of COVID-19 and have a 70 percent higher risk of death when compared with non-pregnant women.
“This moment is the culmination of more than six years of creating, building, and validating a better way to deliver care to expectant mothers. With our first enterprise contract, we mark INVU’s transformation into a marketplace reality,” said Oren Oz, founder and CEO of Nuvo Group. “We’re honored and excited that our first U.S. partner for commercial adoption is Axia Women’s Health, a renowned innovator with whom we share a vision to advance maternal and fetal health through state-of-the-art technology and tools that empower providers and expectant mothers while expanding care delivery. We are thrilled to be able to harness the combined power of our proprietary sensor band and AI platform to transform care delivery for Axia Women’s Health patients.”
“At Axia Women’s Health, our vision is to lead the way in improving women’s health,” said Charlie Choi, CEO of Axia Women’s Health. “Axia and Nuvo have closely-aligned missions, and we are both committed to more progressive care for women. This commercial agreement reflects Axia’s dedication to better serving our patients and advancing payer partnerships through value-based care supported by meaningful technology innovation and better care analytics to improve patients’ experience and outcomes.”